FUNCTIONAL INTERLEUKIN-2 RECEPTORS ARE EXPRESSED ON NATURAL KILLER-LIKE LEUKEMIC-CELLS FROM A DOG WITH CUTANEOUS LYMPHOMA

被引:21
作者
HELFAND, SC
MODIANO, JF
MOORE, PF
SOERGEL, SA
MACWILLIAMS, PS
DUBIELZIG, RD
HANK, JA
GELFAND, EW
SONDEL, PM
机构
[1] UNIV WISCONSIN, SCH VET MED, DEPT PATHOBIOL, MADISON, WI 53706 USA
[2] UNIV WISCONSIN, SCH MED, DEPT HUMAN ONCOL, MADISON, WI 53706 USA
[3] UNIV WISCONSIN, SCH MED, DEPT PEDIAT, MADISON, WI 53706 USA
[4] UNIV WISCONSIN, SCH MED, DEPT GENET, MADISON, WI 53706 USA
[5] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DENVER, CO 80206 USA
[6] UNIV CALIF DAVIS, SCH VET MED, DEPT PATHOL, DAVIS, CA USA
关键词
D O I
10.1182/blood.V86.2.636.bloodjournal862636
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We identified a dog with large granular lymphocytic leukemia and cutaneous lymphoma that exhibited constitutive expression of interleukin-2 (IL-2) receptors by the leukemic peripheral blood lymphocytes. The leukemic cells phenotypically resembled natural killer (NK) cells, and their surface IL-2 receptors were functional, as determined by the capacity to bind human recombinant IL-2 with high-affinity resulting in the transduction of proliferation signals and in the development of lymphokine-activated killer cell activity. These cells produced IL-2 spontaneously, and they may have maintained their proliferative state through an IL-2-dependent autocrine growth pathway, Our results indicate that neoplastic lymphocytes of syndromes that involve circulating leukemic cells with dermotropism can originate from NK-like cells. Additionally, the data also suggest that proliferative conditions such as these may be the result of the aberrant production of IL-2. Further, this case illustrates the potential for the use of hematopoietic malignancies in the dog as a suitable animal model for immune targeting of IL-2 receptors as a novel treatment approach for similar malignancies of human beings. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:636 / 645
页数:10
相关论文
共 76 条
[1]  
ABRAMS JT, 1991, J IMMUNOL, V146, P1455
[2]  
ABRAMS JT, 1993, CANCER RES, V53, P5501
[3]   A CLONAL CD4-POSITIVE T-CELL LINE ESTABLISHED FROM THE BLOOD OF A PATIENT WITH SEZARY-SYNDROME [J].
ABRAMS, JT ;
LESSIN, S ;
GHOSH, SK ;
JU, W ;
VONDERHEID, EC ;
NOWELL, P ;
MURPHY, G ;
ELFENBEIN, B ;
DEFREITAS, E .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (01) :31-37
[4]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[5]   A VIRAL LONG TERMINAL REPEAT IN THE INTERLEUKIN-2 GENE OF A CELL-LINE THAT CONSTITUTIVELY PRODUCES INTERLEUKIN-2 [J].
CHEN, SJ ;
HOLBROOK, NJ ;
MITCHELL, KF ;
VALLONE, CA ;
GREENGARD, JS ;
CRABTREE, GR ;
LIN, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) :7284-7288
[6]   MONOCLONAL-ANTIBODIES THAT DEFINE CANINE HOMOLOGS OF HUMAN CD ANTIGENS - SUMMARY OF THE FIRST INTERNATIONAL CANINE LEUKOCYTE ANTIGEN WORKSHOP (CLAW) [J].
COBBOLD, S ;
METCALFE, S .
TISSUE ANTIGENS, 1994, 43 (03) :137-154
[7]  
COUTO CG, 1985, J AM VET MED ASSOC, V186, P681
[8]  
COUTO CG, 1992, ESSENTIALS SMALL ANI, P87
[9]  
DAVEY F R, 1991, Current Opinion in Oncology, V3, P13, DOI 10.1097/00001622-199102000-00003
[10]   RETROVIRAL ACTIVATION OF INTERLEUKIN-2 GENE IN A GIBBON APE T-CELL LYMPHOMA LINE [J].
DURAND, DB ;
KAMOUN, M ;
NORRIS, CA ;
HOLBROOK, NJ ;
GREENGARD, JS ;
CRABTREE, GR ;
KANT, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (05) :1723-1734